Samuel Deutsch
Has grant
Chief Scientific Officer
United StatesResearch Interests
Explore related searches
Contact this professor
Get a free first email built on one of their papers, ready for you to edit and send yourself.
About
Samuel Deutsch is the Chief Scientific Officer at Nutcracker Therapeutics in the United States. His research focuses on therapeutic mRNA delivery systems, synthetic biology, and enzyme characterization, as evidenced by his recent publications on peptoid-based nanoparticles and the manipulation of synthetic yeast chromosomes. Dr. Deutsch is also involved in innovative approaches to analyze polysaccharide degradation and has contributed to advancements in gene library design and single-cell genomics.
Recent Grants
Grant: Close
Identification, Biomanufacturing and Characterization of Cyclic DiPeptides (CDPs), a diverse family of chemicals involved in mediating microbial interactions
Open Date: 2015-10-01
Close Date: 2017-09-01
Grant: Close
Development of biosensors for high-throughput functional screening of biosynthetic pathways
Open Date: 2013-10-01
Close Date: 2015-10-01
Grant: Close
Highly Parallelized Synthesis of Microbial Genes Using Oligonucleotide Arrays
Open Date: 2011-10-01
Close Date: 2013-09-01
Grant: Close
Identification of ligno-cellulolytic genes for biomass hydrolysis through metagenomic and synthetic biology approaches
Open Date: 2008-12-01
Close Date: 2010-12-01
Articles (9)
Year:
2024
Year:
2023
Year:
2023
Year:
2022
Year:
2022
Year:
2021
Year:
2021
Year:
2020
Year:
2020
Collaborators (7)
Yasunori Aizawa
Associate professor
Tokyo Institute of Technology
Brian G. Fox
-
Taichi Takasuka
Associate Professor
Hokkaido University
Lisa Z. Scheifele
Loyola University Maryland
Leighanne Basta
Associate Professor
United States Naval Academy
Cornelius Gati
Assistant Professor
University of Southern California
Stephen Withers
The University of British Columbia
ApplyKite TwinLearns as you applyMake your next move.
Prepare your application
Review drafts before you send them.